Showing results (651-660 of 2,570) with videos related to
Sort By:
Pageof 257
The International Journal of Developmental Biology|September 28, 2011
Opposing actions of histone deacetylase 1 and Notch signalling restrict expression of erm and fgf20a to hindbrain rhombomere centres during zebrafish neurogenesisElewys G Lightman, Michael R M Harrison, Vincent T CunliffeEnvironmental Science & Technology|June 21, 2001
Temporal trends, temperature dependence, and relative reactivity of atmospheric polycyclic aromatic hydrocarbonsM Dimashki, L H Lim, R M Harrison, et al.International Journal of Experimental Diabetes Research|May 7, 2002
Renal AT1 receptor protein expression during the early stage of diabetes mellitusLisa M Harrison-Bernard, John D Imig, Pamela K CarminesJournal of the American Medical Informatics Association : JAMIA|April 5, 2019
Clinical impact of intraoperative electronic health record downtime on surgical patientsAndrew M Harrison, Rizwan Siwani, Brian W Pickering, et al.Biochemistry|June 27, 1989
Mössbauer spectroscopic study of the initial stages of iron-core formation in horse spleen apoferritin: evidence for both isolated Fe(III) atoms and oxo-bridged Fe(III) dimers as early intermediatesE R Bauminger, P M Harrison, I Nowik, et al.Healthcare Quarterly (Toronto, Ont.)|March 26, 2008
Easing the burden for joint replacement wait times: the role of the expanded practice physiotherapistAlice B Aiken, Mark M Harrison, Marg Atkinson, et al.Policy, Politics & Nursing Practice|August 24, 2018
Paid Family Leave to Enhance the Health Outcomes of Preterm InfantsAshley Weber, Tondi M Harrison, Deborah Steward, et al.Development (Cambridge, England)|July 3, 2024
Exploring the reciprocity between pioneer factors and developmentMeghan M Freund, Melissa M Harrison, Eliana F Torres-ZeladaMultiple Sclerosis and Related Disorders|November 30, 2023
A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosisShishir Dahal, Yohance M Allette, Kerry Naunton, et al.Vascular Pharmacology|March 21, 2003
Pramanicin, an antifungal agent, raises cytosolic Ca2+ and causes cell death in vascular endothelial cellsChiu-Yin Kwan, Paul H M Harrison, Tony K KwanPageof 257